Safety, tolerability, pharmacokinetics, pharmacodynamics and immunogenicity of subcutaneous and intravenous ALXN1720 in healthy volunteers: a phase 1, randomized, double-blind, placebocontrolled, single and multiple ascending dose study

被引：2

作者：

Ortiz, Stephan ^{[1
]}

McEneny, Alanna ^{[1
]}

Amancha, Praveen ^{[1
]}

Rice, Kara ^{[1
]}

Scholz, Joachim ^{[1
]}

Rakhade, Sanjay ^{[1
]}

Yee, Min ^{[1
]}

机构：

[1] Alexion, AstraZeneca Rare Dis, Boston, MA USA

来源：

NEUROLOGY | 2023年 / 100卷 / 17期

关键词：

D O I：

10.1212/WNL.0000000000203482

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

P1-5.016

引用

页数：3

共 50 条

[31] A single-center, randomized, placebo-controlled, double-blind study to evaluate the safety, tolerability, and pharmacokinetics of multiple-ascending doses of pridopidine in healthy volunteers
Osterberg, O.
Ivkovic, J.
Sundgreen, C.
Muglia, P.
Prang, A.
Darpo, B.
NEUROTHERAPEUTICS, 2013, 10 (01) : 175 - 175
[32] A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Ascending Multiple Oral Doses of CC 930 in Healthy Volunteers
Kong, Linghui
Ye, Ying
Liu, Liangang
Reyes, Josephine
Wan, Yuntao
Wu, Anfan
Lau, Henry
Laskin, Oscar
JOURNAL OF CLINICAL PHARMACOLOGY, 2011, 51 (09): : 1343 - 1343
[33] A randomized, double-blind, placebo-controlled, single ascending dose study to evaluate the safety, tolerability, pharmacokinetics, and pharmacodynamics of CBP-201 administered to healthy adult subjects
Royal, Mike A.
White, Jeffery
Snyder, Ben
Wei, Zheng
Pan, Wubin
Wang, Junying
Sansone, Kenneth J.
Yang, Xin
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2020, 83 (06) : AB159 - AB159
[34] Phase 1, Randomized, Double-Blind, Placebo-Controlled Studies of the Safety, Tolerability and Pharmacokinetics of Naldemedine in Healthy Volunteers
Fukumura, Kazuya
Yokota, Takaaki
Baba, Yuko
Camilo, Juan
Ferreira, Arjona
GASTROENTEROLOGY, 2016, 150 (04) : S537 - S538
[35] Phase 1, Randomized, Double-Blind, Placebo-Controlled Studies on the Safety, Tolerability, and Pharmacokinetics of Naldemedine in Healthy Volunteers
Fukumura, Kazuya
Yokota, Takaaki
Baba, Yuko
Ferreira, Juan Camilo Arjona
CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT, 2018, 7 (05): : 474 - 483
[36] Safety, Tolerability and Pharmacokinetics of Dalcetrapib Following Single and Multiple Ascending Doses in Healthy SubjectsA Randomized, Double-Blind, Placebo-Controlled, Phase I Study
Michael Derks
Judith Anzures-Cabrera
Lynn Turnbull
Mary Phelan
Clinical Drug Investigation, 2011, 31 : 325 - 335
[37] Safety, Tolerability and Pharmacokinetics of Dalcetrapib Following Single and Multiple Ascending Doses in Healthy Subjects A Randomized, Double-Blind, Placebo-Controlled, Phase I Study
Derks, Michael
Anzures-Cabrera, Judith
Turnbull, Lynn
Phelan, Mary
CLINICAL DRUG INVESTIGATION, 2011, 31 (05) : 325 - 335
[38] Results from a phase 1, randomized, double-blind, multiple ascending dose study characterizing the pharmacokinetics and demonstrating the safety and selectivity of the aldosterone synthase inhibitor baxdrostat in healthy volunteers
Freeman, Mason W.
Bond, Mary
Murphy, Brian
Hui, James
Isaacsohn, Jonathan
HYPERTENSION RESEARCH, 2023, 46 (01) : 108 - 118
[39] Results from a phase 1, randomized, double-blind, multiple ascending dose study characterizing the pharmacokinetics and demonstrating the safety and selectivity of the aldosterone synthase inhibitor baxdrostat in healthy volunteers
Mason W. Freeman
Mary Bond
Brian Murphy
James Hui
Jonathan Isaacsohn
Hypertension Research, 2023, 46 : 108 - 118
[40] A phase I, randomized, double-blind, placebo-controlled, ascending single- and multiple-dose study of the pharmacokinetics, safety, and tolerability of oral ceftibuten in healthy adult subjects
Hernandez-Mitre, Maria Patricia
Wallis, Steven C.
Morgan, Elizabeth E.
Dudley, Michael N.
Loutit, Jeffery S.
Griffith, David C.
Roberts, Jason A.
Shields, Ryan K.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2024, 68 (01)

← 1 2 3 4 5 →